Circulating Tumor Cells (CTC) Market

Circulating Tumor Cells (CTC) Market Size and Growth Rate:

Circulating Tumor Cells (CTC) Market is valued USD 5 billion in 2016 is anticipated to grow USD 22.5 billion with the compounded annual growth of 18.20% over the forecast period 2018-2025.

Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer are expected to boost usage rates of CTC tests in the coming years. Growing incidences oncology diseases and the introduction of novel biotechnological methods that enable the isolation and quantitation of circulating tumor cells. Furthermore, other factors like early disease diagnosis, cost savings on multiple treatments, drug safety, patient compliance, and optimization of therapies are attributive for rising demand for the preventive medicine, thus influencing the demand for CTC tests.

Circulating Tumor Cells (CTC) Market Growth Drivers:

Growing incidences oncology diseases and the introduction of novel biotechnological methods that enable the isolation and quantitation of circulating tumor cells. Furthermore, other factors like early disease diagnosis, cost savings on multiple treatments, drug safety, patient compliance, and optimization of therapies are attributive for rising demand for the preventive medicine, thus influencing the demand for CTC tests.

Circulating Tumor Cells (CTC) Market Regional Presence:

North America has had the dominating market share in the global market. It held the share of over 48% in 2016. Asia Pacific is estimated to witness a significant growth over the next decade.

Circulating Tumor Cells (CTC) Market Prominent Key Players:

1. Adna Gen AG
2. Advanced Cell Diagnostics
3. Apocell Inc.
4. Aviva Biosciences
5. Biocept Inc.
6. Biofludica Inc
7. Canopus Biosciences Ltd
8. Celltraffix Inc.
9. Clearbridge Biomedics pte ltd

Circulating Tumor Cells (CTC) Market – Detailed Segmentation:

Circulating Tumor Cells (CTC) Market Analysis – By Technology:

• CTC Enrichment Method
• CTC Detection Method
• CTC Analysis

Circulating Tumor Cells (CTC) Market Analysis – By Application:

• Cancer Cell Research
• EMT biomarkers Development
• Tumorigenesis Research

Circulating Tumor Cells (CTC) Market Analysis – By Geographical Segmentation:

• North America                                                       
• Europe                                                             
• Asia-Pacific                                                      
• Latin America                                                     
• Middle-East & Africa